Bloomberg Billionaires Index

View profiles for each of the world’s 500 richest people, see the biggest movers, and compare fortunes or track returns.

#61 Ernesto Bertarelli $16.1B

Random fact: Bought back Serono's Geneva headquarters in 2013.

Overview

Bertarelli inherited Geneva-based drug manufacturer Serono with his sister, Dona. The family sold its stake in the company for 10.7 billion Swiss francs ($8.6 billion) in 2006. The siblings have interests in real estate, hedge funds and health care. Bertarelli also owns sailing team Alinghi that twice won the America's Cup.

As of July 25, 2017:
Last change -$54.2M (-0.3%)
YTD change +$1.88B (+13.2%)
Industry Diversified
Biggest asset Cash
Citizenship Switzerland
Age 51
Wealth Inherited
View net worth over:   Max 1 year 1 quarter 1 month 1 week

Relative Value

Ernesto Bertarelli's net worth of $16.1B can buy ...

0
troy ounces of gold
0
barrels of crude oil

... and is equivalent to ...

0%
of the GDP of the United States
0%
of the total wealth of the 500 richest people in the world
0%
of the top 100 U.S. college endowments
0%
of the top 200 U.S. executives’ total awarded compensation
0%
of U.S. existing home sales
0
times the median U.S. household income

Latest News

Net Worth Summary

Cash
Private asset
Public asset
Misc. liabilities
Confidence rating:

The majority of the Bertarelli fortune is derived from the 65 percent stake in drugmaker Serono, which was sold to Merck for 10.7 billion Swiss francs ($8.6 billion) in 2006, according to a company statement. Since then, Bertarelli has diversified his holdings into hedge funds, private equity and real estate through Geneva-based investment vehicle Waypoint Capital.

Bertarelli owns London property through investment firm Crosstree Real Estate. They're valued by indexing their reported purchase prices to the performance of London office properties, according to data compiled by researcher Real Capital Analytics. 

Geneva-based Ares Life Sciences was established in 2008. It owns stakes in European life sciences companies, including 9 percent of publicly traded Santhera Pharmaceuticals and 84 percent of listed allergy medicine manufacturer Stallergenes Greer, which was formed in September 2015 from the merger of Bertarelli-controlled Stallergenes and Greer Laboratories.

The family collected almost $1 billion selling more than 1.9 million shares of Serono in an initial public offering in 2000. Cash holdings are based on an analysis of asset sales and purchases, taxes and market performance. Market performance is based on a hybrid of indexes that capture sectors his family is known to invest in, including Swiss real estate, hedge funds, private equity and European health-care companies.

Ernesto's credited with the entire fortune, including stakes held by sister Dona and mother, Maria Iris, to reflect his control of the family's investments.

Biography

Birthdate: 9/22/1965
Family: Married, 3 children
Education: 1993, Harvard Business School, MBA 1988, Babson College, Bachelor's Degree

Ernesto and Dona Bertarelli were born in Rome, to Fabio and Maria Iris Bertarelli. Father Fabio worked for Serono, a pharmaceutical company controlled by the Vatican that developed the hormonal fertility drug Pergonal. By the early 1970s, Bertarelli took majority control of Serono by acquiring shares on the open market and renamed it Ares-Serono. He moved the business -- and his family -- to Geneva in 1977.

A year later, the world's first test-tube baby was born to parents using Pergonal. The company shot to prominence, and sold shares in an initial public offering on the Swiss stock exchange, in 1987. It released Gonal-F in 1996, a synthetic infertility drug to replace Pergonal, which required the harvesting of human urine. That same year, Fabio Bertarelli, ill with cancer, handed over control of the company to his 31-year-old son, Ernesto.

The company sold several successful drugs in the late 1990s. Among them were Rebif, a multiple sclerosis medication, and Saizen, which treated growth hormone deficiency in children. Serono sold additional shares on the New York Stock Exchange in 2000, for $1.8 billion. The Bertarellis sold the family's 64.5 percent stake in the company to Merck KGaA for $8.6 billion, in September 2006.

Ernesto now manages the family's assets as chairman of Geneva-based Waypoint Capital, under which sit several holding companies, including Jersey-based investment management firm Kedge Capital and the family's London asset management business Northill. His yacht-racing team, Alinghi, was the first European team to win the America's Cup, in 2003, and successfully defended its title in 2007. Oracle billionaire Larry Ellison's yacht club sued multiple times over Alinghi's proposed format for the 2010 America's Cup, which the Swiss team, with Bertarelli at the helm, would eventually lose to its American rival. Bertarelli chose not to race in the 2013 America's Cup and his team continues to participate in other major race events.

Sister Dona is also an avid sailor and competes on an international women's team that races on Lake Geneva during regatta season. Her catamaran, Ladycat, won the Bol d'Or Mirabaud race in 2010 and she founded sailing team Spindrift in 2011. She is co-president of the Bertarelli Foundation and also owns the Grand Hotel Park in Gstaad, Switzerland.

Milestones
  • 1965 Ernesto Bertarelli born in Rome.
  • 1995 Takes over from father to become Serono chief executive.
  • 1998 Father Fabio dies, control of Serono passes to immediate family.
  • 2000 Serono raises $1.8 billion in an offering on the New York Stock Exchange.
  • 2000 Marries Kirsty Roper, a song writer. They have three children.
  • 2003 Alinghi wins its first America's Cup race.
  • 2006 Sells Serono to German drugmaker Merck for $8.6 billion.
  • 2013 Buys Serono's Geneva headquarters with billionaire Hansjoerg Wyss.